Challenging Management of Warfarinised Patients with Intracranial Hemorrhage Following a Head Injury: A Major Medical Dilemma

Document Type : Review Article

Authors

1 Cardiologist, Fellowship of Echocardiography, Preventive Cardiovascular Care Research Center, Faculty of medical science, Mashhad University of Medical Sciences, Mashhad, Iran

2 Cardiac Surgeon, Department of Cardiac Surgery, Faculty of Medical Sciences, Farshchian Heart Center, Hamedan University of Medical Sciences, Hamedan, Iran

3 Cardiac Surgeon, Department of Cardiac Surgery, Faculty of Medical Sciences. Mashhad University of Medical Sciences, Mashhad, Iran

4 General Physician, Faculty of Medical Science, Mashhad University of Medical Sciences, Mashhad, Iran

5 Student Research Committee, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad

6 Cardiac Surgeon, Department of Cardiac Surgery, Faculty of Medical Sciences, Mashhad University of Medical Sciences, Mashhad. Iran

Abstract

Introduction:The use of anticoagulant and ant platelet medications, especially warfarin and clopidogrel, is on a growing trend. Warfarin usage is commonly accompanied with hemorrhagic complications resulting in a noticeable mortality rate. Patient's ant coagulated with warfarin suffers from intracranial hemorrhage after a head injury.
Materials and Methods: For the purpose of the study, the relevant articles published from 1966 to January 2017 were searched in several databases, including of Medline, Scopus, Google Scholar, and MEDLINE (through PubMed). The search process was performed using the following medical subject headings: “Warfarin” combined with “Warfarin-associated hemorrhage”, “Head injury and warfarin-related intracranial hemorrhage”, “Intracerebral hemorrhage”, and “Treatment of coagulopathy”.
Results: The search process resulted in the inclusion of 242 articles. According to the results of the reviewed studies, the best treatments for the reversal of coagulopathy in warfarinised patients in elective or urgent conditions following a head injury are prothrombin complex concentrate (PCC) and fresh frozen plasma, along with vitamin K, based on the discretion of the treating physician.
Conclusion: According to the studies, the administration of PCC or any other treatments with a similar or close formulation to PCC is significantly more effective and faster in the reversal of coagulopathy and reduction of international normalized ratio in comparison with the use of fresh frozen plasma or other therapies in warfarinised patients admitted with serious intracranial hemorrhage following a head injury. Delivery of an effective treatment to these patients can be accomplished by planning for medical interventions, decreasing time delays for operations, and selecting a suitable or alternative treatment.

Keywords

References

1-Collins CE, Witkowski ER, Flahive JM, Anderson Jr FA, Santry HP. Effect of preinjury warfarin use on outcomes after head trauma in Medicare beneficiaries. The American Journal of Surgery. 2014 Oct 1;208(4):544-9.
2-Virjo I, Mäkelä K, Aho J, Kalliola P, Kurunmäki H, Uusitalo L, Valli M, Ylinen S. Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland. Scandinavian journal of primary health care. 2010 Dec 1;28(4):237-41.
 
3-Pozzessere A, Grotts J, Kaminski S. Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin. Am Surg. 2015 Oct;81(10):1039-42.
4- Frumkin K. Rapid reversal of Warfarin-Associated Hemorrhage in the Emergency Department by Prothrombin Complex Concentrates.Annals of Emergency Medicine.2013;62, 616-626.
5-Maria I.Aguilar, Robert G.Hart, Carlos S.Kase, WillamD.Freeman, Maj Barbara J, Rosa C, Jack E, Stephan A.Mayer, Bo Norrving, Jonathan Rosand, Thorsten Steiner, Eelco F.M, Takenori Yamaguchi, Masahiro Yasaka. Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion. Mayo Clin Proc.2007; 82, 82-92.
6-Daniel K. Nishijima, MAS, Steven R.Offerman, Dustin W. Ballard, David R.Vinson, Uli K Chettipally, Adina S.Rauchwerger, Mary E Reed, James F. Holmes. Immediate and delayed traumatic Intracranial Hemorrhage in patients with head trauma and preinjury warfarin or Clopidogrel use.Annals of Emergency Medicine.2012;59, 460-468.
7-Matsushima K, Benjamin E, Demetriades D. Prothrombin complex concentrate in trauma patients. The American Journal of Surgery.2015; 209, 413-417.
8-Davenport R. Pathogenesis of acute traumatic coagulopathy. Transfusion 2013;53:23S–7S.
 
9-Veshchev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit. 2002;8:CS98-100.
 
10-Moeinipour A, SepehriShamlo A, Lotfalizadeh M, Esfehanizadeh J, Motahedi B, Hoseinikhah H. Evaluation of the last guidelines and studies in anticoagulation regime in pregnant women with prosthetic heart valve. Iranian Journal of Gynecology and Infertility. 2015; 18, 15-19
 
11- Le Roux P, Charles V.Pollack, Milan M, Schaefer A. Race against the clock: Overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. Journal of Neurosurgery.2014;121, 1-20 .
 
12- Bakaeean B, Kabiri M, Iranfar H, Saberi MR, Chamani J. Binding effect of common ions to human serum albumin in the presence of norfloxacin: investigation with spectroscopic and zeta potential approaches. Journal of Solution Chemistry. 2012; 41, 1777-1801.
 
13- Rowell SE, Barbosa RR, Diggs BS, Schreiber MA, Trauma Outcomes Group. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. Journal of Trauma and Acute Care Surgery. 2011 Aug 1;71(2):S353-7.
 
14- Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, Matijevic N, Dong JF, Pati S, Wade CE, Trauma Outcomes Group. Increased platelet: RBC ratios are associated with improved survival after massive transfusion. Journal of Trauma and Acute Care Surgery. 2011 Aug 1;71(2):S318-28.
 
15- Hamed-Akbari Tousi S, Saberi MR, Chamani J. Comparing the Interaction of cyclophosphamide monohydrate to human serum albumin as opposed to holo-transferrin by spectroscopic and molecular modeling methods: evidence for allocating the binding site. Protein and peptide letters. 2010; 17(12), 1524-1535.
 
16- Inaba K, Lustenberger T, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Talving P, Demetriades D. The impact of platelet transfusion in massively transfused trauma patients. Journal of the American College of Surgeons. 2010 Nov 1;211(5):573-9.
 
17- Duchesne JC, Kimonis K, Marr AB, Rennie KV, Wahl G, Wells JE, Islam TM, Meade P, Stuke L, Barbeau JM, Hunt JP. Damage control resuscitation in combination with damage control laparotomy: a survival advantage. Journal of Trauma and Acute Care Surgery. 2010 Jul 1;69(1):46-52.
 
18- Duchesne JC, McSwain Jr NE, Cotton BA, Hunt JP, Dellavolpe J, Lafaro K, Marr AB, Gonzalez EA, Phelan HA, Bilski T, Greiffenstein P. Damage control resuscitation: the new face of damage control. Journal of Trauma and Acute Care Surgery. 2010 Oct 1;69(4):976-90.
 
19- Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB, Inflammation and the Host Response to Injury Investigators. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. Journal of Trauma and Acute Care Surgery. 2009 Aug 1;67(2):221-30.
 
20- Housaindokht MR, Chamani J, Saboury AA, Moosavi-Movahedi AA, Bahrololoom M. Three binding sets analysis of alpha-Lactalbumin by interaction of tetradecyl trimethyl ammonium bromide. Bulletin-Korean Chemical Society. 2001;22(2):145-148.
 
21- Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Spinella PC, Shulman I, Nelson J, Demetriades D. Impact of the duration of platelet storage in critically ill trauma patients. Journal of Trauma and Acute Care Surgery. 2011 Dec 1;71(6):1766-74.
 
22-Towfighi A, Greenberg S, Rosand J: Treatment and prevention of primary intracerebral hemorrhage. Semin Neurol 2005, 25:445-452.
 
23-Steiner T, Rosand J, Diringer M: Intracerebral hemorrhage associated with oral anticoagulant therapy. Stroke 2006, 37:256-262.
 
24- Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston FE. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and haemostasis. 1997 Mar 1;77(3):477-80.
 
25-Fredriksson K, Norrving B, Stromblad LG: Emergency reversal of anticoagulation after intracranial hemorrhage. Stroke 1992, 23:972-977.
 
26- Cartmill, G. Dolan, JL Byrne, PO Byrne M. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. British journal of neurosurgery. 2000 Jan 1;14(5):458-61.
 
27-Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999 Nov 1;45(5):1113-9.
 
28- Zolfagharzadeh M, Pirouzi M, Asoodeh A, Saberi MR, Chamani J. A comparison investigation of DNP-binding effects to HSA and HTF by spectroscopic and molecular modeling techniques. Journal of Biomolecular Structure and Dynamics. 2014;32(12):1936-1952.
 
29-Safaoui M, Aazami R, Hotz H, Wilson M, Margulies D. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage. The American Journal of Surgery. 2009;197, 785-790.
 
30- Chen Y. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage: Goldstein JN, Thomas SH, Frontiero V, et al. Stroke 2006; 37: 151–5. Journal of Emergency Medicine. 2006 May 1;30(4):477.
 
31-Yasaka M, Oomura M, Ikeno K, Naritomi H, Minematsu K. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Ann Hematol. 2003 Feb;82:121-123.
 
32- Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res. 2002;108:25-30.
29-Bertram M, Bonsanto M, Hacke W, Schwab S. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247:209-214.
 
33- Majeed A, Eelde A, Ågren A, Schulman S, Holmström M. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thrombosis research. 2012 Feb 1;129(2):146-51.
 
34- Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. American journal of hematology. 2008 Feb 1;83(2):137-43.
 
35- Joseph B, Amini A, Friese RS, Houdek M, Hays D, Kulvatunyou N, Wynne J, O'keeffe T, Latifi R, Rhee P. Factor IX complex for the correction of traumatic coagulopathy. Journal of Trauma and Acute Care Surgery. 2012 Apr 1;72(4):828-34.
 
36- Yanamadala V, Walcott B, Fecci P, Rozman P, Kumar J, Nahed B, Swearingen. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.Journal of Clinical Neuroscience. 2014; 21, 1881-1884.
 
37-Barillari G, Pasca S, Barillari A, De Angelis V. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.Blood transfusion J. 2012; 10, 87-94.
 
38- Toth P, Van Veen JJ, Robinson K, Maclean RM, Hampton KK, Laidlaw S, Makris M. Real world usage of PCC to “rapidly” correct warfarin induced coagulopathy.Blood transfusion. 2013; 11, 500-505.
 
39- Bechtel B, Nunez T, Lyon J A, Cotton B, Barrett T. Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review.International Journal of Emergency Medicine. 2011; 4:40.
 
40-Appelboam R, Thomas EO: Warfarin and intracranial haemorrhage. Blood Rev 2009, 23:1-9.
 
41- Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. Thrombosis and haemostasis. 2011 Sep;106(03):429-38.
 
42-Masotti L, Di Napoli M, Godoy DA, Rafanelli D, Liumbruno G, Koumpouros N, Landini G, Pampana A, Cappelli R, Poli D, Prisco D. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. International Journal of Stroke. 2011 Jun;6(3):228-40.
 
43- Sanei H, Asoodeh A, Hamedakbari-Tusi S, Chamani J. Multi-spectroscopic investigations of aspirin and colchicine interactions with human hemoglobin: binary and ternary systems. Journal of Solution Chemistry. 2011;40(11):1905-1931.
 
44- AliAsgharMoeinipour, AhmadrezaZarifian,  MohammadSobhan Sheikh Andalibi,AlirezaSepehriShamloo, Ali Ahmadabadi, Ahmad Amouzeshi,  Hamid Hoseinikhah. The Best Anticoagulation Therapy in Multiple-Trauma Patients with MechanicalHeart Valves: Evaluation of Latest Guidelines and Studies. The Heart Surgery Forum #2015-1348. 18 (6), 2015 [Epub December 2015]. doi: 10.1532/hsf.1348
 
45- Ostini R, Hegney D, Mackson JM, Williamson M, Tett SE. Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and drug safety. 2008 Nov;17(11):1077-90.
 
Journal of Cardio-Thoracic Medicine
Volume 7, Issue 1
March 2019
Pages 395-399

Files

Share

How to cite

Statistics